Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer

BACKGROUND: Chemoresistance is a main obstacle in gastric cancer (GC) treatment, but its molecular mechanism still needs to be elucidated. Here, we aim to reveal the underlying mechanisms of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) resistance in GC. METHODS: We performed RNA sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Mengxuan, Zhang, Pengfei, Yu, Shan, Tang, Cheng, Wang, Yan, Shen, Zhenbin, Chen, Weidong, Liu, Tianshu, Cui, Yuehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740411/
https://www.ncbi.nlm.nih.gov/pubmed/34996504
http://dx.doi.org/10.1186/s13046-021-02224-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740411/
https://www.ncbi.nlm.nih.gov/pubmed/34996504
http://dx.doi.org/10.1186/s13046-021-02224-x

Ejemplares similares